1 – 8 of 8
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
(
- Contribution to journal › Article
- 2020
-
Mark
Costs of diabetes complications : hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
(
- Contribution to journal › Article
-
Mark
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective
(
- Contribution to journal › Article
- 2012
-
Mark
Hälsoekonomiska modeller vid diabetes: ett hjälpmedel för klinisk forskning och behandlingsval
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2009
-
Mark
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
(
- Contribution to journal › Article
- 2005
-
Mark
Cost differences for COPD with and without physician-diagnosis
(
- Contribution to journal › Article
- 2004
-
Mark
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease
(
- Contribution to journal › Article
- 2002
-
Mark
Costs of COPD in Sweden according to disease severity
(
- Contribution to journal › Article